TY  - GEN 
AU  - Garrós, Núria
AU  - Clares Naveros, Beatriz
PY  - 2022
UR  - https://hdl.handle.net/10481/77195
AB  - Sjogren's syndrome is a chronic systemic autoimmune disease affecting from 0.2 to 3% of the general population. The current treatment for Sjogren's syndrome is aimed at controlling symptoms such as dry eyes and xerostomia. Systemic therapy with...
LA  - eng
PB  - MDPI
KW  - Sjögren’s syndrome
KW  - Liposomes
KW  - Baricitinib
KW  - JAK inhibitor
KW  - Ocular delivery
KW  - Transcorneal permeation
KW  - Transscleral permeation
KW  - Ocular tolerance
TI  - Baricitinib Liposomes as a New Approach for the Treatment of Sjögren’s Syndrome
DO  - 10.3390/pharmaceutics14091895
ER  -